A cost analysis by researchers at the University of Chicago Medicine shows treatment plans that set individualized blood sugar goals for diabetes patients, tailored to their age and health history, can save $13,546 in health care costs over their average lifetime when compared with treatment strategies that stick to a uniform national standard. More
The University of Chicago Medicine celebrated the completion of what will be the city’s newest and most advanced adult emergency department when the $39 million facility opens to patients in late December. More than 150 people, including public officials, community representatives and faith leaders, were on hand for the Dec. 5 celebration, which included a ribbon-cutting ceremony and community tours of the new state-of-the-art emergency department. More
Visit the Department of Medicine’s Women Committee here and check out the latest newsletter for the most recent Committee news here.
A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help physicians make better treatment choices for patients with gastric and esophageal adenocarcinoma. Many current approaches to genome-guided therapy, often referred to as “precision medicine,” have produced imprecise results. This is particularly the case for gastric and esophageal adenocarcinoma (GEA), which are common cancers. They can be difficult to control and are often detected and diagnosed late. They frequently recur after surgery, and those recurrences … Read More
The University of Chicago Medicine earned its 12th consecutive “A” in patient safety from The Leapfrog Group, a prominent hospital-watchdog organization. The grade, announced Oct. 31, makes the Hyde Park-based academic health system one of only 59 hospitals in the county to earn a dozen sequential top marks since Leapfrog began producing its twice-a-year survey in June 2012. The nonprofit group’s latest survey reviewed data from more than 2,600 hospitals across the country. More
Yoav Gilad, PhD, Professor of Medicine, has been appointed as Vice Chair for Research effective November 1, 2017. Dr. Gilad is an internationally acclaimed leader in the fields of human genetics, gene regulation, and genome biology . Dr. Gilad’s research focuses on advancing our understanding of the genetics of complex phenotypes by studying intermediate molecular data, such as gene regulatory states within and across populations and species. He uses both human and non-human primate models to understand how changes in gene regulation can explain human diseases, and how individual cells vary and differ from each other. Understanding this variability has … Read More
The FDA approved a breakthrough cancer treatment for adult patients with relapsed or refractory diffuse large B-cell lymphoma, a form of non-Hodgkin lymphoma, that uses genetically engineered immune cells to target cancer. More
Marshall Chin, MD, Richard Parrillo Family Professor of Healthcare Ethics, has been elected to the National Academy of Medicine. This prestigious honor reflects his extraordinary contributions towards improving the care and outcomes for vulnerable patients with chronic disease and reducing health disparities. Dr. Chin joins five faculty from the Department of Medicine, Graeme Bell, PhD, Robert Gibbons, PhD, David Meltzer, MD, PhD, Olufunmilayo Olopade, MD, and Kenneth Polonsky, MD, as elected members of NAM. Dr. Chin received his MD from the University of California at San Francisco in 1989, followed by his primary care residency training at Brigham and … Read More
Check out the 2017 Department of Medicine Annual Report entitled “Powerful Connections”. You can view the annual report by clicking the link here.
Southern Illinois University School of Medicine and the University of Chicago Medicine will use a $1.13 million federal grant to study the opioid epidemic affecting the state’s 16 southernmost counties. The joint effort will initially focus on learning how and why people use opioids such as heroin, fentanyl and prescription painkillers for non-medical reasons and examine the impact on health. People with opioid use disorder, particularly those who inject the drugs, are more vulnerable to outbreaks of HIV, hepatitis and other infections. More